Omeros Corporation
Nucleic acids encoding antibodies specifically binding to MASP-3
Last updated:
Abstract:
The present invention relates to MASP-3 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-3 dependent complement activation.
Status:
Grant
Type:
Utility
Filling date:
1 Apr 2020
Issue date:
18 Aug 2020